$BRKR News

Last published 1w ago

1w agoBRKRBruker Corporation Q3 2026 Earnings Webcast - BRUKER CORPEarnings Call TranscriptsGood morning everyone and welcome to the Bruker Corporation third quarter 2026 earnings conference call. All participants will be in a listen-only mode. Should you need assistance please see no conference specialist by p
1w agoBRKRBRUKER CORP - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
3w agoBRKRBruker Announces Date and Time of Third Quarter 2026 Earnings Release and WebcastBusiness WireBruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2026 financial results before market opening on Wednesday, November 4, 2026. The Company will host a conference call and webcast at 8:30
1mo agoBRKRUntargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform ResolutionBusiness WireCharité principal investigator Markus Ralser and colleagues discover and map 179,000 plasma proteoforms, revealing a vast molecular landscape for functional proteomics in biomedical research, drug discovery and
1mo agoBRKRBruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology ResearchBusiness WireMultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP ProteoScape connects PASEF discovery with rapid prm-PASEF target validation Spectronaut® AI transfer learning accelerates
1mo agoBRKRBruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC BerkeleyBusiness WireNew high-field NMR instrumentation strengthens biomolecular and materials science research at the UC Berkeley Pines Magnetic Resonance Center Bruker Corporation (NASDAQ:BRKR) today announced a multi-system order from
1mo agoBRKR BRKRPMorgan Stanley 24th Annual Global Healthcare Conference - BRUKER CORPEarnings Call TranscriptsAll right. Thank you, everyone, for being here. It's my pleasure to welcome the Bruker team to the Morgan Stanley Healthcare Conference. My name is Mike Fadal. I lead Morgan Stanley's life science tools and diagnostic pr
2mo agoBRKR BRKRPWells Fargo 21st Annual Healthcare Conference - BRUKER CORPEarnings Call TranscriptsGood morning, everyone. Welcome to day two of the Wells Fargo Health Care Conference. We're happy to have Bruker here and late surprise guest, CEO Frank Lakin and Gerald Herman, CFO. Frank is just returning from Europe,
2mo agoBRKRBruker Corporation to Present at Upcoming Investor ConferencesBusiness WireBruker Corporation (NASDAQ:BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in Boston, MA Wednesday, September 9, 2026 at 8:00
2mo agoBRKRBEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement FusionBusiness WireRRP Preferred for High-Field Demonstration and First-of-a-Kind Power Plant OpportunitiesBruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (NASDAQ:BRKR), and Luvata Materials &
3mo agoBRKRBruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving LaboratoriesBusiness WireEnables deeper integration of Atinary's SDLabs platform with Chemspeed automation, Bruker instruments and SciY software for closed-loop agentic AI-driven R&D Bruker Corporation (NASDAQ:BRKR) today announced
3mo agoBRKRBruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and DevelopmentBusiness WireMIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions Bruker Corporation (NASDAQ:BRKR) today announced a majority investment in
3mo agoBRKR BRKRPBruker Corporation Q2 2026 Earnings Webcast - BRUKER CORPEarnings Call TranscriptsGood day and welcome to the Berger Corporation Second Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the
3mo agoBRKRBruker Reports Second Quarter 2026 Financial ResultsBusiness WireQ2-26 Bruker Scientific Instruments (BSI) bookings up 10% organically year-over-year (yoy), with BSI book-to-bill >1.0x Q2-26 revenue of $838.5 million, up +5.2% yoy; up 2.8% organically, or +3.4% excluding
3mo agoBRKRBruker Announces Date and Time of Second Quarter 2026 Earnings Release and WebcastBusiness WireBruker Corporation (NASDAQ:BRKR) today announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026. The Company will host a conference call and webcast at 9:00 a.m.
3mo agoBRKRBruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in BloodBusiness WireBruker Corporation (NASDAQ:BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH.This press release features multimedia. View the full release here:
5mo agoBRKR BRKRPBRUKER CORPORATION JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN NEW YORKBRUKER CORPEarnings Call TranscriptsWe're going to kick it off. I'm Tucker Peterson from the Healthcare Group. It's my pleasure to introduce Brooker. We've got Gerald with us. Welcome. Thank you very much. Let's maybe just kick off with a quick one-cue rec
5mo agoBRKRBruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026Business WireAt ASM Microbe 2026, Bruker Corporation's (NASDAQ:BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis
5mo agoBRKRBruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy IndustryBusiness WireAt ASMS, Bruker Corporation (NASDAQ:BRKR) announced the launch of the new timsMRMS system, designed to empower researchers in petroleomics, sustainable fuels and advanced energy storage. The timsMRMS is an innovative
5mo agoBRKRBruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease BiologyBusiness WireBruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing Launch of eXtreme 10M resolution novel timsMRMS™ mass
5mo agoBRKRChampalimaud Foundation's Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRIBusiness WireWorld's highest-field MRI system provides leading disease biology research capabilities Bruker Corporation announced the commissioning of a novel BioSpec™ 18 Tesla preclinical MRI, the world's highest-field
6mo agoBRKR BRKRPBruker Corporation Q1 2026 Earnings WebcastBRUKER CORPEarnings Call TranscriptsGood day and welcome to the Brooker Corporation First Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the
6mo agoBRKRBruker Reports First Quarter 2026 Financial ResultsBusiness WireQ1 2026 revenues of $823.4 million, up 2.7% year-over-year (yoy), down 4.4% organically Q1-26 GAAP diluted earnings per share (EPS) $0.02; non-GAAP diluted EPS $0.31 Q1-26 Bruker Scientific Instruments (BSI)
6mo agoBRKRBruker Announces Date and Time of First Quarter 2026 Earnings Release and WebcastBusiness WireBruker Corporation (NASDAQ:BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and webcast at 8:00 a.m.
6mo agoBRKRBruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026Business WireBruker Spatial Biology features new GeoMx-to-CellScape and CellScape-to-CosMx cross-platform workflows and first-of-its-kind 208-plex CellScape XR spatial proteomics datasets Bruker Corporation (NASDAQ:BRKR) today
6mo agoBRKRBruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak ManagementBusiness WireMALDI Biotyper® (MBT): Launch of proprietary MBT Easy T® Kit for consistent sample transfer to MALDI target plates MALDI Biotyper®: Expansion of reference libraries to more than 5,300 species,
6mo agoBRKRBruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026Business WireAt ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division ((Bruker Corporation, NASDAQ:BRKR) announces the European launch of MyGenius PRO®, a fully automated, sample-to-answer (S2A)
7mo agoBRKRBruker Unveils New NMR Products and Workflow Solutions at ENC 2026Business WireIntroductions span console electronics, quantitative NMR software, 80 MHz benchtop FT‑NMR, solid‑state and dissolution DNP, and automated protein and RNA workflows. At the Experimental Nuclear Magnetic Resonance
7mo agoBRKRBruker Invests in Photothermal AFM-IR to Advance Semiconductor ResearchBusiness WireDimension IconIR to Support Critical Materials Characterization for Next-Generation Semiconductor Devices Bruker Corporation (NASDAQ:BRKR) today announced accelerated development of its photothermal AFM-IR
7mo agoBRKRBruker Announces Appointment of Thierry Bernard to its Board of DirectorsBusiness WireBruker Corporation (NASDAQ:BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry
7mo agoBRKRPreOmics GmbH and Biognosys AG Prevail in U.S. Patent ChallengeBusiness WireUS PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024‑01473 before
8mo agoBRKRBruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XRBusiness WireThe new platform delivers unmatched quantitation, robustness, and throughput to support clinical translation of spatial proteomics assays Bruker Corporation (NASDAQ:BRKR) announced the launch of CellScape™ XR,
8mo agoBRKRBruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic ApplicationsBusiness WireBruker Spatial Biology, a division of Bruker Corporation (NASDAQ:BRKR) announced today that it will expand its collaboration with Noetik Inc., following their prior study of more than 3500 patient samples with the
8mo agoBRKRBruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological SpectrumBusiness WirePortfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome visualization,
8mo agoBRKRBruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease BiologyBusiness WireNovel timsOmni™ workflows enable deeper functional characterization of proteoforms and PTMs, leveraging multi-stage, ultra-sensitive trapped eXd molecular fragmentation Bruker ProteoScape™ expands
9mo agoBRKR BRKRPBruker Corporation Q4 2025 Earnings WebcastBRUKER CORPEarnings Call TranscriptsGood morning, everyone, and welcome to the Beruker Corporation Fourth Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference speciali
9mo agoBRKRBruker Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness WireQ4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted EPS of $0.59 FY25 revenues of $3.44 billion, up ~2% yoy,
9mo agoBRKRChemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI OrchestrationBusiness WireAt SLAS2026, Chemspeed Technologies, a leader in the automation and digitalization of R&D and QC laboratories, and SciY, a leader in scientific and laboratory management software focused on lab standardization and
9mo agoBRKRBruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QCBusiness WireNew iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows Bruker Corporation today announced the
9mo agoBRKR BRKRPBruker Announces Quarterly Preferred Stock DividendBusiness WireBruker Corporation (NASDAQ:BRKR, BRKRP)) today announced that its Board of Directors ("Board") has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company's 6.375% Mandatory
9mo agoBRKRBruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and WebcastBusiness WireBruker Corporation (NASDAQ:BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thursday, February 12, 2026. The Company will host a conference call and
10mo agoBRKRBruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRIBusiness WireThe Bruker Energy & Supercon Technologies (BEST) division, a segment of Bruker Corporation (NASDAQ:BRKR), today announced two multi-year supply agreements for Bruker's latest superconductors, which are used by
10mo agoBRKRRI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)Business WireRI Research Instruments, a company that is majority-owned by Bruker Corporation (NASDAQ:BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of the Extreme Light
11mo agoBRKRBruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European InstitutionsBusiness WireBruker Corporation (NASDAQ:BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: This press release
11mo agoBRKR BRKRPBruker Earnings Call - BRUKER CORPEarnings Call TranscriptsWelcome, everyone. It's great to have you. Welcome, Gerald Herrmann, CFO of Brooker. Hello. I'm Aisha Noor, European MedTech Analyst with Morgan Stanley, and it's my pleasure to host this fireside chat today with Brooker
11mo agoBRKRBruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026Business WireBruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1st, 2026. Mr. Phillips is a senior healthcare industry
11mo agoBRKRIndaba Capital Announces Sale of AST Revolution to BrukerBusiness WireIndaba Capital Management, L.P. ("Indaba"), controlling shareholder of AST Revolution, LLC ("AST Revolution" or the "Company"), today announced the sale of AST Revolution to Bruker Corporation ("Bruker") (NASDAQ:BRKR,
1y agoBRKR BRKRPBruker Announces Quarterly Common Stock Dividend and Preferred Stock DividendBusiness WireBruker Corporation (NASDAQ:BRKR, BRKRP)) today announced that its Board of Directors ("Board") has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock, par value
1y agoBRKRBruker Reports Third Quarter 2025 Financial ResultsBusiness WireQ3 2025 revenues of $860.5 million, down 0.5% year-over-year (yoy), down 4.5% organically Q3 2025 GAAP diluted loss per share $(0.41); non-GAAP diluted earnings per share (EPS) $0.45 Updated FY2025
1y agoBRKRBruker Announces Date and Time of Third Quarter 2025 Earnings Release and WebcastBusiness WireBruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2025 financial results before market opening on Monday, November 3, 2025. The Company will host a conference call and webcast at 8:30 a.m.